Shopping Cart 0
Cart Subtotal
USD 0

Alfresa Holdings Corp (2784) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Alfresa Holdings Corp (Alfresa) is a manufacturer and marketer of pharmaceuticals, diagnostic reagent and medical devices. The company offers ethical pharmaceuticals wholesaling, self-medication products and manufacturing. It's ethical pharmaceutical wholesaling business supplies diagnostic reagents, medical devices and equipment to hospitals, clinics, dispensing pharmacies and other institutions. Alfresa's self-medication products wholesaling business offer health foods, supplements, cosmetics, and other products to drugstores and pharmacies. The company offers comprehensive healthcare services by broadening its operational scale and scope. It markets its products in Japan and abroad. Alfresa is headquartered in Chiyoda-Ku, Tokyo, Japan.

Alfresa Holdings Corp (2784)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alfresa Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Alfresa Pharma to Acquire 41 Products from Daiichi Sankyo 12

Partnerships 13

Sanofi Enters Into Co-Development Agreement With Alfresa For Antiepileptic Drug 13

Acquisition 14

Alfresa to Acquire Sannova from Eisai 14

Alfresa Completes Acquisition Of Tokiwa Yakuhin 15

Alfresa Acquires Remaining 48.98% Stake In Kowa Pharma 17

Alfresa Holdings Corp-Key Competitors 18

Alfresa Holdings Corp-Key Employees 19

Alfresa Holdings Corp-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 22

Corporate Communications 22

Dec 21, 2017: Alfresa Announces Appointment and Resignation for Representative Directors 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alfresa Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alfresa Holdings Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Alfresa Pharma to Acquire 41 Products from Daiichi Sankyo 12

Sanofi Enters Into Co-Development Agreement With Alfresa For Antiepileptic Drug 13

Alfresa to Acquire Sannova from Eisai 14

Alfresa Completes Acquisition Of Tokiwa Yakuhin 15

Alfresa Acquires Remaining 48.98% Stake In Kowa Pharma 17

Alfresa Holdings Corp, Key Competitors 18

Alfresa Holdings Corp, Key Employees 19

Alfresa Holdings Corp, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Alfresa Holdings Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Alfresa Holdings Corp (Alfresa) is a manufacturer and marketer of pharmaceuticals, diagnostic reagent and medical devices. The company offers ethical pharmaceuticals wholesaling, self-medication products and manufacturing. It's ethical pharmaceutical wholesaling business supplies diagnostic reagents, medical devices and equipment to hospitals, clinics, dispensing pharmacies and other institutions. Alfresa's self-medication products wholesaling business offer health foods, supplements, cosmetics, and other products to drugstores and pharmacies. The company offers comprehensive healthcare services by broadening its operational scale and scope. It markets its products in Japan and abroad. Alfresa is headquartered in Chiyoda-Ku, Tokyo, Japan.

Alfresa Holdings Corp (2784)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alfresa Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Alfresa Pharma to Acquire 41 Products from Daiichi Sankyo 12

Partnerships 13

Sanofi Enters Into Co-Development Agreement With Alfresa For Antiepileptic Drug 13

Acquisition 14

Alfresa to Acquire Sannova from Eisai 14

Alfresa Completes Acquisition Of Tokiwa Yakuhin 15

Alfresa Acquires Remaining 48.98% Stake In Kowa Pharma 17

Alfresa Holdings Corp-Key Competitors 18

Alfresa Holdings Corp-Key Employees 19

Alfresa Holdings Corp-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 22

Corporate Communications 22

Dec 21, 2017: Alfresa Announces Appointment and Resignation for Representative Directors 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Alfresa Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Alfresa Holdings Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10

Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Alfresa Pharma to Acquire 41 Products from Daiichi Sankyo 12

Sanofi Enters Into Co-Development Agreement With Alfresa For Antiepileptic Drug 13

Alfresa to Acquire Sannova from Eisai 14

Alfresa Completes Acquisition Of Tokiwa Yakuhin 15

Alfresa Acquires Remaining 48.98% Stake In Kowa Pharma 17

Alfresa Holdings Corp, Key Competitors 18

Alfresa Holdings Corp, Key Employees 19

Alfresa Holdings Corp, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Alfresa Holdings Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.